$7.58
0.030.4%
가까이에: Aug 24, 5:00 PM EST
$7.06
-0.49-6.49%
프리마켓: 4:01 AM EST
Benzinga
Benzinga
Benzinga
수요일, 8월 26
Harvard Bioscience Inc
HBIONASDAQ
Harvard Bioscience Earnings & Forecasts
Harvard Bioscience (HBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Harvard Bioscience Guidance
Harvard Bioscience (HBIO)는 8월 11, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $89.15M - $90.88M 범위로 예상했습니다.
이전 가이던스와 비교하여 Harvard Bioscience는 매출 전망치를 이전 범위인 상향 조정됨에서 $21M - $22.6M로 상향 조정했습니다.
Harvard Bioscience은 16과 11월 8, 2022 사이에 8월 11, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 5 times and lowered it 7 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.15 | $-0.03 | $0.30 | $0.10 |
| Actual | $-0.14 | $-0.33 | $0.00 | $0.00 |
| Surprise | +6.67% | -1000.0% | -100.0% | -100.0% |
| Revenue | ||||
| Estimate | $21.4M | $21.2M | $23.1M | $20.0M |
| Actual | $22.7M | $20.8M | $23.7M | $20.6M |
| Surprise | +5.95% | -2.10% | +2.75% | +2.95% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.13 | $0.26 |
| Revenue | ||
| Consensus | $21.4M | $24.5M |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved